Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Income towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOther Operating ExpensesResearch & DevelopmentShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Intelligent Bio Solutions (INBS) Net Income towards Common Stockholders (2019 - 2025)

Intelligent Bio Solutions has reported Net Income towards Common Stockholders over the past 6 years, most recently at -$2.8 million for Q2 2024.

  • For Q2 2024, Net Income towards Common Stockholders fell 4.04% year-over-year to -$2.8 million; the TTM value through Jun 2024 reached -$10.4 million, up 16.24%, while the annual FY2024 figure was -$10.3 million, 18.29% up from the prior year.
  • Net Income towards Common Stockholders for Q2 2024 was -$2.8 million at Intelligent Bio Solutions, up from -$3.0 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at -$111107.0 in Q1 2020 and troughed at -$6.4 million in Q1 2023.
  • A 5-year average of -$2.2 million and a median of -$2.1 million in 2022 define the central range for Net Income towards Common Stockholders.
  • Biggest five-year swings in Net Income towards Common Stockholders: plummeted 2728.5% in 2021 and later surged 57.23% in 2022.
  • Year by year, Net Income towards Common Stockholders stood at -$2.0 million in 2020, then crashed by 74.03% to -$3.5 million in 2021, then soared by 38.52% to -$2.1 million in 2022, then rose by 5.13% to -$2.0 million in 2023, then plummeted by 39.17% to -$2.8 million in 2024.
  • Business Quant data shows Net Income towards Common Stockholders for INBS at -$2.8 million in Q2 2024, -$3.0 million in Q1 2024, and -$2.0 million in Q4 2023.